Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Frontiers in Medicine
|
January 6, 2022
TRIM29 in Cutaneous Squamous Cell Carcinoma
Che-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie
Clinical Drug Investigation
|
September 25, 2019
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
Nai-Lun Yeh, Che-Yuan Hsu, Tsen-Fang Tsai, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 1, 2023
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
Kai-Wen Chuang, Che-Yuan Hsu, Shiu-Wen Huang, et al.
Toxicology and Applied Pharmacology
|
December 15, 2007
In vivo immunomodulatory effects of Antrodia camphorata polysaccharides in a T1/T2 doubly transgenic mouse model for inhibiting infection of Schistosoma mansoni
Po-Ching Cheng, Che-Yuan Hsu, Chin-Chu Chen, et al.
Indian Journal of Dermatology
|
March 26, 2026
Dermoscopic Features of Porocarcinoma: Report of 11 Cases and Review of the Literature
Kodai Miyamoto, Teruki Yanagi, Takuya Maeda, et al.
Cellular Signalling
|
May 9, 2006
Negative regulation of protease-activated receptor 1-induced Src kinase activity by the association of phosphocaveolin-1 with Csk
Te-Ling Lu, Fang-Ting Kuo, Te-Jung Lu, et al.
International Journal of Environmental Research and Public Health
|
December 24, 2021
Smoking Cessation Rate and Its Predictors among Heavy Smokers in a Smoking-Free Hospital in Taiwan
Chin-Jung Lin, Wei-Hsin Huang, Che-Yuan Hsu, et al.
Scientific Reports
|
May 27, 2023
Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
Che-Yuan Hsu, Teruki Yanagi, Takuya Maeda, et al.
British Journal of Cancer
|
May 29, 2025
An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells
Che-Yuan Hsu, Teruki Yanagi, Kodai Miyamoto, et al.
British Journal of Cancer
|
July 10, 2024
Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism
Che-Yuan Hsu, Teruki Yanagi, Takuya Maeda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Frontiers in Medicine
|
January 6, 2022
TRIM29 in Cutaneous Squamous Cell Carcinoma
Che-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie
Clinical Drug Investigation
|
September 25, 2019
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
Nai-Lun Yeh, Che-Yuan Hsu, Tsen-Fang Tsai, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 1, 2023
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
Kai-Wen Chuang, Che-Yuan Hsu, Shiu-Wen Huang, et al.
Toxicology and Applied Pharmacology
|
December 15, 2007
In vivo immunomodulatory effects of Antrodia camphorata polysaccharides in a T1/T2 doubly transgenic mouse model for inhibiting infection of Schistosoma mansoni
Po-Ching Cheng, Che-Yuan Hsu, Chin-Chu Chen, et al.
Indian Journal of Dermatology
|
March 26, 2026
Dermoscopic Features of Porocarcinoma: Report of 11 Cases and Review of the Literature
Kodai Miyamoto, Teruki Yanagi, Takuya Maeda, et al.
Cellular Signalling
|
May 9, 2006
Negative regulation of protease-activated receptor 1-induced Src kinase activity by the association of phosphocaveolin-1 with Csk
Te-Ling Lu, Fang-Ting Kuo, Te-Jung Lu, et al.
International Journal of Environmental Research and Public Health
|
December 24, 2021
Smoking Cessation Rate and Its Predictors among Heavy Smokers in a Smoking-Free Hospital in Taiwan
Chin-Jung Lin, Wei-Hsin Huang, Che-Yuan Hsu, et al.
Scientific Reports
|
May 27, 2023
Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
Che-Yuan Hsu, Teruki Yanagi, Takuya Maeda, et al.
British Journal of Cancer
|
May 29, 2025
An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells
Che-Yuan Hsu, Teruki Yanagi, Kodai Miyamoto, et al.
British Journal of Cancer
|
July 10, 2024
Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism
Che-Yuan Hsu, Teruki Yanagi, Takuya Maeda, et al.
Page
of 2